Results 1 to 10 of about 26,419 (210)

Arrhythmogenic Right Ventricular Cardiomyopathy and Cor Triatriatum Dexter: An Unreported Association. [PDF]

Clin Case Rep
We present a 74‐year‐old patient with a previous diagnosis of arrhythmogenic right ventricular cardiomyopathy manifesting as heart failure where a concomitant cor triatriatum dexter has accidentally been diagnosed by echocardiography.
Franco E, Rovera C, Moretti C, Bassareo PP.   +3 more
europepmc   +2 more sources

The mystery behind recurrent pericardial effusions: A hidden case of arrhythmogenic right ventricular cardiomyopathy. [PDF]

Radiol Case Rep
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare but potentially life- threatening genetic disorder characterized by fibrofatty myocardial replacement, ventricular dysfunction, and arrhythmias.
Bouyaddid S, Ouaddouh Y, Ismaili N, El Ouafi N, Bazid Z.   +4 more
europepmc   +2 more sources

Multimodality imaging in arrhythmogenic cardiomyopathy [PDF]

Romanian Journal of Cardiology, 2021
Arrhythmogenic cardiomyopathy, as it has been recently redefined, is characterized by progressive myocyte loss with fibrosis and fat infiltration of the myocardium, which finally leads to a broad clinical spectrum ranging from heart failure symptoms to ...
Laura Tapoi, Alexandra Clement, Rodica Radu, Radu Sascau   +3 more
doaj   +1 more source

Left Ventricular Dysfunction in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Can We Separate ARVC From Other Arrhythmogenic Cardiomyopathies?

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Arrhythmogenic right ventricular cardiomyopathy was first described as a right ventricular disease that is an important cause of death in young adults. However, with the advent of advanced imaging, arrhythmogenic right ventricular cardiomyopathy has been
Stephan Altmayer, Saman Nazarian, Yuchi Han   +2 more
doaj   +1 more source

Novel Risk Prediction Model to Determine Adverse Heart Failure Outcomes in Arrhythmogenic Right Ventricular Cardiomyopathy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Patients with arrhythmogenic right ventricular cardiomyopathy are at risk for life‐threatening ventricular tachyarrhythmias, but progressive heart failure (HF) may occur in later stages of disease.
Shi Chen, Liang Chen, Ardan M. Saguner, Kai Chen, Deniz Akdis, Alessio Gasperetti, Corinna Brunckhorst, Hanwei Tang, Guangran Guo, Man Rao, Xiangjie Li, Jiangping Song, Firat Duru, Shengshou Hu   +13 more
doaj   +1 more source

Prominent Epsilon Waves in a Patient With Cardiac Sarcoidosis

JACC: Case Reports, 2020
Epsilon waves are the surface manifestation of myocardial regions with delayed activation and are considered the hallmark of arrhythmogenic right ventricular cardiomyopathy.
Kevin J. Mills, MD, Mauricio Sendra Ferrer, MD, Mario D. Gonzalez, MD   +2 more
doaj   +1 more source

Arrhythmogenic Cardiomyopathy—Further Insight into the Clinical Spectrum of Desmoplakin Disease

Cardiogenetics, 2021
Arrhythmogenic cardiomyopathy is a familial heart muscle disease characterized by structural, electrical, and pathological abnormalities. Recognition of left ventricular (LV) involvement in arrhythmogenic right ventricular cardiomyopathy (ARVC) has led ...
Joanne Simpson, Joan Anusas, Denise Oxnard, Sylvia Wright, Ruth McGowan, Caroline Coats   +5 more
doaj   +1 more source

Establishment of a Dedicated Inherited Cardiomyopathy Clinic: From Challenges to Improved Patients’ Outcome

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Inherited cardiomyopathies (ICs) are relatively rare. General cardiologists have little experience in diagnosing and managing these conditions. International societies have recognized the need for dedicated IC clinics.
Emily Smith, Paul D. Thompson, Carolyn Burke‐Martindale, Adaya Weissler‐Snir   +3 more
doaj   +1 more source

The year in cardiology: arrhythmias and pacing. [PDF]

, 2020
During this last year, there has been much progress with regard to anticoagulant and ablation therapy for atrial fibrillation (AF). Apart from recently issued European Society of Cardiology Guidelines for the management of patients with supraventricular ...
Calkins, H, Camm, AJ, Lip, GYH, Schilling, R, Steffel, J   +4 more
core   +4 more sources

Sudden cardiac death in young athletes: Literature review of molecular basis [PDF]

, 2020
Intense athletic training and competition can rarely result in sudden cardiac death (SCD). Despite the introduction of pre-participation cardiovascular screening, especially among young competitive athletes, sport-related SCD remains a debated issue ...
Barbara Lombardo, Bruno Mirra, Cristina Mazzaccara, Ferdinando Barretta, Giulia Frisso, Olga Scudiero   +5 more
core   +1 more source